Syntheses Cryogenic Chemistry Made Easy

Editor: Ahlam Rais

The newly developed Cryoflowskid enables 3 step syntheses for the continuous production of chemical intermediates or active pharmaceutical ingredients in kg quantities per hour.

Related Companies

Cryoflowskid by De Dietrich Process Systems incorporates flow reactors from Innosyn.
Cryoflowskid by De Dietrich Process Systems incorporates flow reactors from Innosyn.
(Source: De Dietrich Process Systems)

In particular, syntheses with highly exothermic reaction steps and proceeding through unstable intermediates can be carried out in the Cryoflowskid with significantly higher efficiency than with a batch process. Thus the technology for e.g. organometallic chemistry can often be considerably intensified. The compact, mobile system can be operated in a typical chemical pilot plant environment and it is fully automated. The solution is highly modular so that the reactors can be easily exchanged. The system was developed by De Dietrich Process Systems together with Innosyn.

Innosyn contributes to the chemical process know-how and the flow reactors. Its core components are manufactured from different metals in a 3D printing process. De Dietrich Process Systems, as the manufacturer of the entire system, is responsible for the engineering, production and worldwide sales and service of the complete system. For this joint co-operation the two companies signed a collaboration contract.

China’s Pharmaceutical Equipment Market - Current Status, Trends and Recommendations for Action

As China is emerging as one of the world’s fastest-growing markets for the consumption of pharmaceuticals, it also offers huge opportunities for the global equipment industry. This 40-page report aims to help you gain a better understanding of the current China's pharmaceutical market regarding a series of pharmaceutical industry related policies. Based on results of the survey among users in the pharmaceutical industry and the expert interviews, it will also provide you with a forecast for the industry and recommendations for your future operating and investment in China.

(ID:46699702)